Overview
BTAI market data
Price History
No market bars yet for BTAI. This page will populate once the next provider sweep lands.
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for BTAI. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
[Latest] Global AI in Drug Repurposing Market Size/Share Worth USD 10.56 Billion by 2035 at a 23.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)Globenewswire Inc · Jul 21, 2026, 10:00 PM
BigBear.ai Introduces New Capabilities To Offer Flexibility To U.S. Department Of War Mission Team For Generative AIBenzinga · Jul 15, 2026, 1:18 PM
8-K filing — BioXcel Therapeutics, Inc. (BTAI)SEC EDGAR · Jul 6, 2026, 10:00 AM
BioXcel Presents New Data From Phase 3 SERENITY At-Home Trial Evaluating BXCL501 For Acute Treatment Of Agitation Associated With Bipolar Disorders Or Schizophrenia At 2026 ASCP Annual MeetingBenzinga · May 28, 2026, 11:10 AM
Earnings Scheduled For May 15, 2026Benzinga · May 15, 2026, 11:15 AM
BioXcel Therapeutics Q1 EPS $(0.54) Beats $(0.59) Estimate, Sales $206.000K Miss $349.250K EstimateBenzinga · May 15, 2026, 11:10 AM